DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 05 · Volume 45 · Juli 2012 DOI: 10.1055/s-002-23423

Review

  • 167
    Riemann, D.; Spiegelhalder, K.; Nissen, C.; Hirscher, V.; Baglioni, C.; Feige, B.:

    REM Sleep Instability – A New Pathway for Insomnia?

    • Original Paper

  • 177
    Li, Y.-M.; Zhao, J.-P.; Ou, J.-J.; Wu, R.-R.:

    Efficacy and Tolerability of Ziprasidone vs. Olanzapine in Naive First-Episode Schizophrenia: A 6-Week, Randomized, Open-Label, Flexible-Dose Study

  • 182
    Huber, M.; Kölzsch, M.; Rapp, M. A.; Wulff, I.; Kalinowski, S.; Bolbrinker, J.; Hofmann, W.; Scholze, J.; Dräger, D.; Kreutz, R.:

    Antipsychotic Drugs Predominate in Pharmacotherapy of Nursing Home Residents with Dementia

  • 189
    Stein, M.; Dietrich, D. E.; Agelink, M. W.; Becker, W.; Chrysanthou, C.; Driessen, M.; Kruse, G.; Machleidt, W.; Reker, T.; Schneider, U.; Schulze Mönking, H.; Emrich, H. M.; Arolt, V.; Rothermundt, M.:

    Naturalistic Pharmacotherapy of Acute Episodes of Schizophrenic Disorders in Comparison to Treatment Guidelines

  • 196
    Schoemaker, J.; Stet, L.; Vrijland, P.; Naber, D.; Panagides, J.; Emsley, R.:

    Long-Term Efficacy and Safety of Asenapine or Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder: An Extension Study

    • Letter

  • 204
    Loayza, N.; Crettol, S.; Riquier, F.; Eap, C. B.:

    Adherence to Antidepressant Treatment: What the Doctor Thinks and What the Patient Says